FKBP51异形的差异动力学和作用及其对向疗法的影响
Silvia Martinelli1, Kathrin Hafner1, Maik Koedel1
1Department Genes and Environment, Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany.
International journal of molecular sciences
|November 27, 2024
概括
FKBP5基因有两个蛋白质变体. 较短的FKBP51变体被葡萄糖皮质激素快速上调,寿命较短,具有独特的细胞功能,影响药物设计.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- FKBP5基因表达和FKBP51蛋白是由葡萄糖皮质醇诱导的.
- 现有的研究缺乏了解FKBP5RNA拼接变体和蛋白质异型.
- FKBP51蛋白质有两个异构体,其中一个缺乏功能性C端基因.
研究的目的:
- 调查FKBP5RNA拼接变体和蛋白质异型的差异性作用.
- 分析FKBP51异型体的动态表达和细胞局部.
- 为了比较FKBP51异型体对下游细胞通路的功能影响.
主要方法:
- 在体外细胞模型 (HeLa,Jurkat) 和人类外周血液细胞.
- 德克萨米他刺激诱导FKBP5的表达.
- 蛋白质降解试验和亚核局部化研究.
- 下游途径的分析:葡萄糖皮质体受体功能,自,免疫激活,DNA甲基化.
主要成果:
- 这两种FKBP51变体都在体外和体内都受到德克萨米他的上调.
- 较短的FKBP51单体表现出明显较早的上调 (1-2小时) 和缩短的半衰期 (4小时而不是8小时).
- 只有较短的异构体表现出亚核局部化和对细胞通路的差异性影响.
结论:
- 两种FKBP51异型表现出不同的表达动态,稳定性,局部化和功能影响.
- 对FKBP51变种的差异分析对于未来的研究至关重要.
- 了解异形特异性功能对向药物设计有影响.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Nonlinear Pharmacokinetics: Role of Transporters
33
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
33
Factors Affecting Protein-Drug Binding: Protein-Related Factors
124
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
124


